- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Monkeypox Therapeutics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Monkeypox Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Monkeypox Therapeutics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Monkeypox Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Monkeypox Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Monkeypox Therapeutics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Monkeypox Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Monkeypox Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chimerix Inc., SIGA Technologies, Inc., Emergent BioSolutions Inc., Bavarian Nordic A/S and Hetero Drugs Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Monkeypox Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Smallpox Vaccine
Antivirals
Vaccinia Immune Globulin (VIG)
Market segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others
Market segment by players, this report covers
Chimerix Inc.
SIGA Technologies, Inc.
Emergent BioSolutions Inc.
Bavarian Nordic A/S
Hetero Drugs Limited
Mylan N.V.
Piramal Enterprises Limited
Olon S.p.A.
Teva Pharmaceutical Industries Limited
CIDIC Company Limited
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Monkeypox Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Monkeypox Therapeutics, with revenue, gross margin and global market share of Monkeypox Therapeutics from 2018 to 2023.
Chapter 3, the Monkeypox Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Monkeypox Therapeutics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Monkeypox Therapeutics.
Chapter 13, to describe Monkeypox Therapeutics research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Monkeypox Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Monkeypox Therapeutics by Type
1.3.1 Overview: Global Monkeypox Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Monkeypox Therapeutics Consumption Value Market Share by Type in 2022
1.3.3 Smallpox Vaccine
1.3.4 Antivirals
1.3.5 Vaccinia Immune Globulin (VIG)
1.4 Global Monkeypox Therapeutics Market by Application
1.4.1 Overview: Global Monkeypox Therapeutics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Ambulatory Surgical Centers
1.4.5 Others
1.5 Global Monkeypox Therapeutics Market Size & Forecast
1.6 Global Monkeypox Therapeutics Market Size and Forecast by Region
1.6.1 Global Monkeypox Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Monkeypox Therapeutics Market Size by Region, (2018-2029)
1.6.3 North America Monkeypox Therapeutics Market Size and Prospect (2018-2029)
1.6.4 Europe Monkeypox Therapeutics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Monkeypox Therapeutics Market Size and Prospect (2018-2029)
1.6.6 South America Monkeypox Therapeutics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Monkeypox Therapeutics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Chimerix Inc.
2.1.1 Chimerix Inc. Details
2.1.2 Chimerix Inc. Major Business
2.1.3 Chimerix Inc. Monkeypox Therapeutics Product and Solutions
2.1.4 Chimerix Inc. Monkeypox Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Chimerix Inc. Recent Developments and Future Plans
2.2 SIGA Technologies, Inc.
2.2.1 SIGA Technologies, Inc. Details
2.2.2 SIGA Technologies, Inc. Major Business
2.2.3 SIGA Technologies, Inc. Monkeypox Therapeutics Product and Solutions
2.2.4 SIGA Technologies, Inc. Monkeypox Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 SIGA Technologies, Inc. Recent Developments and Future Plans
2.3 Emergent BioSolutions Inc.
2.3.1 Emergent BioSolutions Inc. Details
2.3.2 Emergent BioSolutions Inc. Major Business
2.3.3 Emergent BioSolutions Inc. Monkeypox Therapeutics Product and Solutions
2.3.4 Emergent BioSolutions Inc. Monkeypox Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Emergent BioSolutions Inc. Recent Developments and Future Plans
2.4 Bavarian Nordic A/S
2.4.1 Bavarian Nordic A/S Details
2.4.2 Bavarian Nordic A/S Major Business
2.4.3 Bavarian Nordic A/S Monkeypox Therapeutics Product and Solutions
2.4.4 Bavarian Nordic A/S Monkeypox Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bavarian Nordic A/S Recent Developments and Future Plans
2.5 Hetero Drugs Limited
2.5.1 Hetero Drugs Limited Details
2.5.2 Hetero Drugs Limited Major Business
2.5.3 Hetero Drugs Limited Monkeypox Therapeutics Product and Solutions
2.5.4 Hetero Drugs Limited Monkeypox Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hetero Drugs Limited Recent Developments and Future Plans
2.6 Mylan N.V.
2.6.1 Mylan N.V. Details
2.6.2 Mylan N.V. Major Business
2.6.3 Mylan N.V. Monkeypox Therapeutics Product and Solutions
2.6.4 Mylan N.V. Monkeypox Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Mylan N.V. Recent Developments and Future Plans
2.7 Piramal Enterprises Limited
2.7.1 Piramal Enterprises Limited Details
2.7.2 Piramal Enterprises Limited Major Business
2.7.3 Piramal Enterprises Limited Monkeypox Therapeutics Product and Solutions
2.7.4 Piramal Enterprises Limited Monkeypox Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Piramal Enterprises Limited Recent Developments and Future Plans
2.8 Olon S.p.A.
2.8.1 Olon S.p.A. Details
2.8.2 Olon S.p.A. Major Business
2.8.3 Olon S.p.A. Monkeypox Therapeutics Product and Solutions
2.8.4 Olon S.p.A. Monkeypox Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Olon S.p.A. Recent Developments and Future Plans
2.9 Teva Pharmaceutical Industries Limited
2.9.1 Teva Pharmaceutical Industries Limited Details
2.9.2 Teva Pharmaceutical Industries Limited Major Business
2.9.3 Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Product and Solutions
2.9.4 Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Teva Pharmaceutical Industries Limited Recent Developments and Future Plans
2.10 CIDIC Company Limited
2.10.1 CIDIC Company Limited Details
2.10.2 CIDIC Company Limited Major Business
2.10.3 CIDIC Company Limited Monkeypox Therapeutics Product and Solutions
2.10.4 CIDIC Company Limited Monkeypox Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 CIDIC Company Limited Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Monkeypox Therapeutics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Monkeypox Therapeutics by Company Revenue
3.2.2 Top 3 Monkeypox Therapeutics Players Market Share in 2022
3.2.3 Top 6 Monkeypox Therapeutics Players Market Share in 2022
3.3 Monkeypox Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Monkeypox Therapeutics Market: Region Footprint
3.3.2 Monkeypox Therapeutics Market: Company Product Type Footprint
3.3.3 Monkeypox Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Monkeypox Therapeutics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Monkeypox Therapeutics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Monkeypox Therapeutics Consumption Value Market Share by Application (2018-2023)
5.2 Global Monkeypox Therapeutics Market Forecast by Application (2024-2029)
6 North America
6.1 North America Monkeypox Therapeutics Consumption Value by Type (2018-2029)
6.2 North America Monkeypox Therapeutics Consumption Value by Application (2018-2029)
6.3 North America Monkeypox Therapeutics Market Size by Country
6.3.1 North America Monkeypox Therapeutics Consumption Value by Country (2018-2029)
6.3.2 United States Monkeypox Therapeutics Market Size and Forecast (2018-2029)
6.3.3 Canada Monkeypox Therapeutics Market Size and Forecast (2018-2029)
6.3.4 Mexico Monkeypox Therapeutics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Monkeypox Therapeutics Consumption Value by Type (2018-2029)
7.2 Europe Monkeypox Therapeutics Consumption Value by Application (2018-2029)
7.3 Europe Monkeypox Therapeutics Market Size by Country
7.3.1 Europe Monkeypox Therapeutics Consumption Value by Country (2018-2029)
7.3.2 Germany Monkeypox Therapeutics Market Size and Forecast (2018-2029)
7.3.3 France Monkeypox Therapeutics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Monkeypox Therapeutics Market Size and Forecast (2018-2029)
7.3.5 Russia Monkeypox Therapeutics Market Size and Forecast (2018-2029)
7.3.6 Italy Monkeypox Therapeutics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Monkeypox Therapeutics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Monkeypox Therapeutics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Monkeypox Therapeutics Market Size by Region
8.3.1 Asia-Pacific Monkeypox Therapeutics Consumption Value by Region (2018-2029)
8.3.2 China Monkeypox Therapeutics Market Size and Forecast (2018-2029)
8.3.3 Japan Monkeypox Therapeutics Market Size and Forecast (2018-2029)
8.3.4 South Korea Monkeypox Therapeutics Market Size and Forecast (2018-2029)
8.3.5 India Monkeypox Therapeutics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Monkeypox Therapeutics Market Size and Forecast (2018-2029)
8.3.7 Australia Monkeypox Therapeutics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Monkeypox Therapeutics Consumption Value by Type (2018-2029)
9.2 South America Monkeypox Therapeutics Consumption Value by Application (2018-2029)
9.3 South America Monkeypox Therapeutics Market Size by Country
9.3.1 South America Monkeypox Therapeutics Consumption Value by Country (2018-2029)
9.3.2 Brazil Monkeypox Therapeutics Market Size and Forecast (2018-2029)
9.3.3 Argentina Monkeypox Therapeutics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Monkeypox Therapeutics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Monkeypox Therapeutics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Monkeypox Therapeutics Market Size by Country
10.3.1 Middle East & Africa Monkeypox Therapeutics Consumption Value by Country (2018-2029)
10.3.2 Turkey Monkeypox Therapeutics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Monkeypox Therapeutics Market Size and Forecast (2018-2029)
10.3.4 UAE Monkeypox Therapeutics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Monkeypox Therapeutics Market Drivers
11.2 Monkeypox Therapeutics Market Restraints
11.3 Monkeypox Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Monkeypox Therapeutics Industry Chain
12.2 Monkeypox Therapeutics Upstream Analysis
12.3 Monkeypox Therapeutics Midstream Analysis
12.4 Monkeypox Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Monkeypox Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Monkeypox Therapeutics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Monkeypox Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Monkeypox Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Chimerix Inc. Company Information, Head Office, and Major Competitors
Table 6. Chimerix Inc. Major Business
Table 7. Chimerix Inc. Monkeypox Therapeutics Product and Solutions
Table 8. Chimerix Inc. Monkeypox Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Chimerix Inc. Recent Developments and Future Plans
Table 10. SIGA Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 11. SIGA Technologies, Inc. Major Business
Table 12. SIGA Technologies, Inc. Monkeypox Therapeutics Product and Solutions
Table 13. SIGA Technologies, Inc. Monkeypox Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. SIGA Technologies, Inc. Recent Developments and Future Plans
Table 15. Emergent BioSolutions Inc. Company Information, Head Office, and Major Competitors
Table 16. Emergent BioSolutions Inc. Major Business
Table 17. Emergent BioSolutions Inc. Monkeypox Therapeutics Product and Solutions
Table 18. Emergent BioSolutions Inc. Monkeypox Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Emergent BioSolutions Inc. Recent Developments and Future Plans
Table 20. Bavarian Nordic A/S Company Information, Head Office, and Major Competitors
Table 21. Bavarian Nordic A/S Major Business
Table 22. Bavarian Nordic A/S Monkeypox Therapeutics Product and Solutions
Table 23. Bavarian Nordic A/S Monkeypox Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bavarian Nordic A/S Recent Developments and Future Plans
Table 25. Hetero Drugs Limited Company Information, Head Office, and Major Competitors
Table 26. Hetero Drugs Limited Major Business
Table 27. Hetero Drugs Limited Monkeypox Therapeutics Product and Solutions
Table 28. Hetero Drugs Limited Monkeypox Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Hetero Drugs Limited Recent Developments and Future Plans
Table 30. Mylan N.V. Company Information, Head Office, and Major Competitors
Table 31. Mylan N.V. Major Business
Table 32. Mylan N.V. Monkeypox Therapeutics Product and Solutions
Table 33. Mylan N.V. Monkeypox Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Mylan N.V. Recent Developments and Future Plans
Table 35. Piramal Enterprises Limited Company Information, Head Office, and Major Competitors
Table 36. Piramal Enterprises Limited Major Business
Table 37. Piramal Enterprises Limited Monkeypox Therapeutics Product and Solutions
Table 38. Piramal Enterprises Limited Monkeypox Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Piramal Enterprises Limited Recent Developments and Future Plans
Table 40. Olon S.p.A. Company Information, Head Office, and Major Competitors
Table 41. Olon S.p.A. Major Business
Table 42. Olon S.p.A. Monkeypox Therapeutics Product and Solutions
Table 43. Olon S.p.A. Monkeypox Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Olon S.p.A. Recent Developments and Future Plans
Table 45. Teva Pharmaceutical Industries Limited Company Information, Head Office, and Major Competitors
Table 46. Teva Pharmaceutical Industries Limited Major Business
Table 47. Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Product and Solutions
Table 48. Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Teva Pharmaceutical Industries Limited Recent Developments and Future Plans
Table 50. CIDIC Company Limited Company Information, Head Office, and Major Competitors
Table 51. CIDIC Company Limited Major Business
Table 52. CIDIC Company Limited Monkeypox Therapeutics Product and Solutions
Table 53. CIDIC Company Limited Monkeypox Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. CIDIC Company Limited Recent Developments and Future Plans
Table 55. Global Monkeypox Therapeutics Revenue (USD Million) by Players (2018-2023)
Table 56. Global Monkeypox Therapeutics Revenue Share by Players (2018-2023)
Table 57. Breakdown of Monkeypox Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Monkeypox Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Monkeypox Therapeutics Players
Table 60. Monkeypox Therapeutics Market: Company Product Type Footprint
Table 61. Monkeypox Therapeutics Market: Company Product Application Footprint
Table 62. Monkeypox Therapeutics New Market Entrants and Barriers to Market Entry
Table 63. Monkeypox Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Monkeypox Therapeutics Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Monkeypox Therapeutics Consumption Value Share by Type (2018-2023)
Table 66. Global Monkeypox Therapeutics Consumption Value Forecast by Type (2024-2029)
Table 67. Global Monkeypox Therapeutics Consumption Value by Application (2018-2023)
Table 68. Global Monkeypox Therapeutics Consumption Value Forecast by Application (2024-2029)
Table 69. North America Monkeypox Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Monkeypox Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Monkeypox Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Monkeypox Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Monkeypox Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Monkeypox Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Monkeypox Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Monkeypox Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Monkeypox Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Monkeypox Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Monkeypox Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Monkeypox Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Monkeypox Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Monkeypox Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Monkeypox Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Monkeypox Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Monkeypox Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Monkeypox Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Monkeypox Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Monkeypox Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Monkeypox Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Monkeypox Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Monkeypox Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Monkeypox Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Monkeypox Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Monkeypox Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Monkeypox Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Monkeypox Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Monkeypox Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Monkeypox Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Monkeypox Therapeutics Raw Material
Table 100. Key Suppliers of Monkeypox Therapeutics Raw Materials
List of Figures
Figure 1. Monkeypox Therapeutics Picture
Figure 2. Global Monkeypox Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Monkeypox Therapeutics Consumption Value Market Share by Type in 2022
Figure 4. Smallpox Vaccine
Figure 5. Antivirals
Figure 6. Vaccinia Immune Globulin (VIG)
Figure 7. Global Monkeypox Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Monkeypox Therapeutics Consumption Value Market Share by Application in 2022
Figure 9. Hospitals Picture
Figure 10. Specialty Clinics Picture
Figure 11. Ambulatory Surgical Centers Picture
Figure 12. Others Picture
Figure 13. Global Monkeypox Therapeutics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Monkeypox Therapeutics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Monkeypox Therapeutics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Monkeypox Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Monkeypox Therapeutics Consumption Value Market Share by Region in 2022
Figure 18. North America Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Monkeypox Therapeutics Revenue Share by Players in 2022
Figure 24. Monkeypox Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Monkeypox Therapeutics Market Share in 2022
Figure 26. Global Top 6 Players Monkeypox Therapeutics Market Share in 2022
Figure 27. Global Monkeypox Therapeutics Consumption Value Share by Type (2018-2023)
Figure 28. Global Monkeypox Therapeutics Market Share Forecast by Type (2024-2029)
Figure 29. Global Monkeypox Therapeutics Consumption Value Share by Application (2018-2023)
Figure 30. Global Monkeypox Therapeutics Market Share Forecast by Application (2024-2029)
Figure 31. North America Monkeypox Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Monkeypox Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Monkeypox Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Monkeypox Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Monkeypox Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Monkeypox Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 41. France Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Monkeypox Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Monkeypox Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Monkeypox Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 48. China Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 51. India Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Monkeypox Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Monkeypox Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Monkeypox Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Monkeypox Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Monkeypox Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Monkeypox Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Monkeypox Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 65. Monkeypox Therapeutics Market Drivers
Figure 66. Monkeypox Therapeutics Market Restraints
Figure 67. Monkeypox Therapeutics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Monkeypox Therapeutics in 2022
Figure 70. Manufacturing Process Analysis of Monkeypox Therapeutics
Figure 71. Monkeypox Therapeutics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
